InspireMD Inc is a medical device company. The Company is engaged in the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease.
| Website: | www.inspire-md.com |
| Main Phone: | +1 857 453-6553 |
| Address: | 321 Columbus Avenue |
| State: | MA |
| City / Town: | Boston |
| Country: | USA |
| Postal Code: | 02116 |
| Exchange: | AMX |
| Employees: | 40 |
| NAICS: | Surgical and Med |
| Last Price 0.32 | Change $ 0.0021 | Change % 0.65 | Tick N/A |
| Bid 0.32 | Bid Size 300.00 | Ask 0.35 | Ask Size 8,200.00 |
| Open 0.33 | High 0.35 | Low 0.32 | Prev Close 0.32 |
| Last Trade | Volume 201,009 | 52 Wk Hi 4.39 | 52 Wk Low 0.30 |
| Market Cap 2.4 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 7,465,889.00 | EPS (TTM) -1.44 | PE Ratio N/A | Exchange NYSE American |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 6 | 29 |
| Number of Buys | 5 | 21 |
| Number of Sells | 1 | 8 |
| Net Activity | 5989274 | 8332106 |
| Last 10 Buys | Shares |
|---|---|
| Paul S. Stuka | 1,000 |
| Paul S. Stuka | 1,000 |
| Sol J. Barer | 1,000 |
| Sol J. Barer | 1,000 |
| Sol J. Barer | 1,000 |
| Campbell Rogers | 1,000 |
| Paul S. Stuka | 1,000 |
| James J. Loughlin | 1,000 |
| James J. Loughlin | 1,000 |
| Campbell Rogers | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Asher Holzer | 1,000 |
| Asher Holzer | 1,000 |
| Asher Holzer | 1,000 |
| Asher Holzer | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 3 | 3 | 3 | 3 |
| Low Target Price Estimate | 3 | 3 | 3 | 3 |
| Mean Target Price Estimate | 3 | 3 | 3 | 3 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 05/11/16 | 05/11/16 | 05/11/16 | 05/11/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 82 | 2016-08-18 |
| 8-K | Report of unscheduled material events or corporate changes. | 27 | 2016-08-10 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 71 | 2016-08-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 13 | 2016-08-09 |
| PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 82 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 8-K | Report of unscheduled material events or corporate changes. | 13 | 2016-07-29 |
| CERTNYS | Certification by the New York Stock Exchange approving securities for listing | 1 | 2016-07-27 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-27 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-27 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
